1. United Kingdom Stocks

  2. •

    Consumer Defensive

  3. •

    Packaged Foods
Tate & Lyle plc

Tate & Lyle plc

TATE.L
Tate & Lyle plcGB flagLondon Stock Exchange
558.50
GBp
-0.50
- -
2.47BMarket Cap
Tate & Lyle plc
TATE.L
(London Stock Exchange)

Recent

price

558.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
FRC
6.88
7.74
8.18
6.92
5.88
5.92
6.92
6.84
6.95
7.24
3.04
3.45
4.33
4.15
4.24
4.54
Revenue per Share
0.41
0.76
0.68
0.69
0.08
0.41
0.64
0.67
0.46
0.62
0.64
0.59
0.47
0.47
0.35
0.22
Basic EPS, GAAP
0.13
0.25
0.29
0.35
0.06
-0.03
0.36
0.39
0.5
0.55
0.55
-0.11
-0.03
0.25
0.11
0.24
Free Cash Flow per Basic Share
0.18
0.28
0.29
0.31
0.33
0.33
0.33
0.33
0.34
0.34
0.34
0.36
1.41
0.19
0.2
0.2
Dividend per Share
0.91
1.23
1.21
1.45
1.16
1.22
1.67
2
2.16
1.87
2.25
2.46
1.56
1.86
1.49
1.43
Book Value per Share
1.65
1.84
1.93
1.87
1.5
1.61
2.34
2.54
2.89
2.66
2.79
3.37
1.83
2.1
1.82
1.82
Tangible Book Value per Share
396
399
398
398
398
398
398
396
397
398
398
399
404
397
409
442
Basic Weighted Avg Shares
2,720
3,088
3,256
2,754
2,341
2,355
2,753
2,710
2,755
2,882
1,211
1,375
1,751
1,647
1,736
2,006
Sales/Revenue/Turnover
11.43
10.98
10.6
9.37
7.48
7.52
9.52
10.52
10.74
11.17
12.72
12.07
13.02
14.27
6.11
12.16
Operating Margin (%)
109
103
108
103
109
115
149
154
152
172
175
100
95
94
128
172
Depreciation Expense
163
305
272
273
30
163
256
265
181
245
253
236
190
188
143
97
Net Income, GAAP
20
19
15.28
11.55
84
3.17
- -
8.04
24.58
17.23
1.11
38.1
16.45
20.4
48.86
25.19
Effective Tax Rate (%)
5.99
9.88
8.35
9.91
1.28
6.92
9.3
9.78
6.57
8.5
20.89
17.16
10.85
11.41
8.24
4.84
Profit Margin (%)
785
698
625
356
226
414
538
526
415
624
745
1,680
712
749
684
841
Working Capital
885
803
816
435
461
554
602
552
371
680
744
656
592
573
1,145
1,274
LT Debt
973
1,058
1,036
1,050
936
1,029
1,332
1,367
1,489
1,399
1,454
1,620
1,190
1,239
1,588
1,598
Total Equity
11.49
13.2
14.63
12.04
1.57
9.57
- -
12.96
10.89
12.49
6.92
4.5
8.94
9.79
2.26
6.21
Return on Invested Capital (%)
13.43
26.07
21.29
22.71
2.74
15.48
- -
21.74
14.52
18.66
17.78
15.09
14.43
15.54
10.19
7.22
Return on Capital (%)
58.74
71.6
55.85
51.51
5.79
34.42
44.44
36.33
21.91
30.55
30.85
25.16
23.57
27.45
21.15
15.58
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.67%
3.56%
0.63%
Free Cash Flow
-252.82%
-204.53%
144.19%
Net Income, GAAP
-1.59%
-16.67%
-32.17%
Sales/Revenue/Turnover
1.95%
11.18%
15.55%
Total Cash Common Dividend
- -
45.91%
10%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1,647
2025
- -
- -
- -
- -
1,736
2026
- -
- -
- -
- -
2,006

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.47
2025
- -
- -
- -
- -
0.35
2026
- -
- -
- -
- -
0.22

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.19
2025
- -
- -
- -
- -
0.2
2026
- -
- -
- -
- -
0.2
Similar Companies
Honworld Group Limited (2226.HK)
Hanover Foods Corporation (HNFSB)
Jiajia Food Group Co.,Ltd (002650.SZ)
Australian Oilseeds Holdings Limited Ordinary Shares (COOT)
China Feihe Limited (CFEIY)
Prataap Snacks Limited (DIAMONDYD.BO)
Business
Tate & Lyle PLC (TATE.L) is a global provider of specialty food and beverage ingredients and solutions, focusing on high-value products that enhance taste, texture, nutrition, and sustainability in consumer and industrial applications. The company offers a diverse portfolio including low- and no-calorie sweeteners such as SPLENDA sucralose and TASTEVA stevia; soluble fibers like PROMITOR; texturants and stabilizers such as CLARIA functional clean-label starch; crystalline fructose under the KRYSTAR brand; pectin and specialty gums through its CP Kelco segment; high-volume sweeteners and industrial starches in Primary Products Europe; and solutions for beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, meat and seafood, personal care, household products, clinical nutrition, and industrial uses. Headquartered in London, United Kingdom, and founded in 1903, Tate & Lyle operates manufacturing facilities and innovation centers across more than 60 locations worldwide, including key sites in the United States, Europe, Asia Pacific, and Latin America, serving food and beverage manufacturers, personal care, and industrial markets. In a major strategic expansion, the company completed its acquisition of CP Kelco from J.M. Huber in November 2024 for approximately £1.4 billion, integrating pectin, specialty gums, and nature-based ingredients to strengthen its texturants portfolio and target growth in the $19 billion specialty ingredients market. Earlier in 2024, Tate & Lyle divested its remaining 49.7% stake in the Primient joint venture to KPS Capital Partners for $350 million, fully exiting legacy bulk corn processing operations to focus on higher-margin specialty solutions; it also extended its regenerative agriculture program into Europe and deepened partnerships like its stevia Reb M collaboration with Manus Bio. These moves support accelerated revenue growth toward 4-6% annually, cost synergies of £40 million, and innovation in sugar reduction, fiber fortification, and GLP-1 medication-aligned consumer trends.